<DOC>
	<DOC>NCT00708071</DOC>
	<brief_summary>The primary objective of this study is to evaluate the efficacy and safety of fibrin sealant with 4 IU/mL thrombin, vapor heated, solvent detergent treated (FS VH S/D 4) when used to reduce early postoperative bruising in participants undergoing a rhytidectomy (face-lift).</brief_summary>
	<brief_title>Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures</brief_title>
	<detailed_description />
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<mesh_term>Aprotinin</mesh_term>
	<criteria>Subjects planned for facial rhytidectomy Subjects who read, understand and sign the written informed consent Healthy female or male subjects as determined by the investigator using standard preoperative assessments to include laboratory tests and ECG Subjects 1875 years old, inclusively Subjects who are able and willing to comply with the protocol requirements Female subjects of childbearing potential with a negative urine or serum pregnancy test within 72 hours of surgery Pregnant or lactating women Subjects who have undergone previous facelift surgery Subjects undergoing abbreviated facelift procedures such as deep plane procedures, minimal undermining procedures, thread lifts, and minimal access cranial suspension Subjects indicated for concurrent facial surgeries during the operation (e.g. forehead plasty, blepharoplasty, rhinoplasty, buccal fat removal, any filler injections including fat injections, lip augmentation, skin resurfacing procedures etc.) Subjects indicated for additional procedures during the same operation (e.g., liposuction, mastoplasty etc.) Subjects who had prior silicone injections to their face (Botox and/or Restylane are allowed) Subjects considered by the investigator to be smokers Subjects with ecchymosis and/or edema on the face on day 0, prior to surgery Subjects with known (documented) bleeding or coagulation disorders Subjects currently being treated with anticoagulants Subjects treated with Aspirin in the last 7 days or use of other Nonsteroidal antiinflammatory drug (NSAIDs) within the last 7 days prior to surgery Subjects with vascular disorders, cardiovascular disease, and/or uncontrolled hypertension Subjects with diabetes mellitus Subjects with a history of BellÂ´s palsy Subjects with connective tissue disorders Subjects with documented history of pathologically or pharmacologically induced immune deficiency Subjects receiving systemic corticosteroid treatment for a chronic condition within 2 to 30 days prior to the surgery Subjects with a known sensitivity to fibrin sealants Subjects with a known psychiatric disorder (e.g., depression, obsessive compulsive disorder, anxiety, eating disorders, etc) Subjects who have participated in another clinical study within 30 days prior to this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>